Status:
UNKNOWN
Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Patients hospitalized for COVID-19 may need intensive care (e.g. mechanical ventilation) during hospitalization. Some risk factors are already known but better targeting of such patients is still need...
Detailed Description
Patients hospitalized for COVID-19 may need intensive care (e.g. mechanical ventilation) during hospitalization. Some risk factors are already known (e.g. sex, comorbidities, initial clinical presenta...
Eligibility Criteria
Inclusion
- Adult patient with documented SARS-CoV-2 infection requiring hospitalization.
Exclusion
- Lack of consent
- Patients hospitalized in an intensive care unit
- Patient under guardianship or curatorship
Key Trial Info
Start Date :
December 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04669938
Start Date
December 4 2020
End Date
August 31 2022
Last Update
June 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LESCURE
Paris, France